Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Pharma
After Avadel setback, Lundbeck signals future M&A rigor
While some analysts have questioned Lundbeck’s prospects following a major patent cliff, company leadership says it will prioritize strategic fit.
Angus Liu
Jan 22, 2026 11:13am
AbbVie will continue to pursue external innovation for long-term
Jul 31, 2025 11:44am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Even through its remake, Alkermes retains upward trajectory: CEO
Jan 13, 2025 7:36am
A revival in neuro therapeutics
Oct 11, 2024 8:37am
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
